Lipocine (LPCN) Cash & Equivalents (2011 - 2025)
Lipocine's Cash & Equivalents came in at $5.21 million for Q4 2025, down 16.1% from $6.21 million a year earlier but up 33.4% from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) Cash & Equivalents (2011 - 2025) Analysis & Trends
Going back to Q4 2011, Lipocine's Cash & Equivalents data covers 56 quarters.
- Cash & Equivalents carries a five-year compound annual growth rate of -23.0% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $6.21 million in FY2024 (+30.1%), $4.77 million in FY2023 (+51.6%), $3.15 million in FY2022 (+6.7%) and $2.95 million in FY2021 (-84.6%).
- The five-year range for quarterly Cash & Equivalents is $2.4 million (Q3 2022) to $15.6 million (Q1 2021).
- Year-over-year, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 0.4%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2023 (growth of 69.9%), and the weakest in Q4 2021 (a decline of 84.6%).
- Business Quant data shows LPCN's Cash & Equivalents at $3.9 million (Q3 2025), $6.04 million (Q2 2025) and $3.35 million (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Lipocine | 11.22 Mn | -56.50 Mn | - | 5.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 5.21 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 6.04 Mn |
| Mar 31, 2025 | 3.35 Mn |
| Dec 31, 2024 | 6.21 Mn |
| Sep 30, 2024 | 3.74 Mn |
| Jun 30, 2024 | 5.55 Mn |
| Mar 31, 2024 | 3.08 Mn |
| Dec 31, 2023 | 4.77 Mn |
| Sep 30, 2023 | 4.07 Mn |
| Jun 30, 2023 | 5.01 Mn |
| Mar 31, 2023 | 4.77 Mn |
| Dec 31, 2022 | 3.15 Mn |
| Sep 30, 2022 | 2.40 Mn |
| Jun 30, 2022 | 4.98 Mn |
| Mar 31, 2022 | 5.73 Mn |
| Dec 31, 2021 | 2.95 Mn |
| Sep 30, 2021 | 4.52 Mn |
| Jun 30, 2021 | 10.97 Mn |
| Mar 31, 2021 | 15.60 Mn |
API Access
Lipocine Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();